Omalizumab exposure patterns in real-life: An 11-year French population-based study of 19,203 patients with severe asthma.

M. Humbert (Le Kremlin-Bicêtre, France), A. Bourdin (Montpellier, France), A. Deschildre (Lille, France), M. Molimard (Bordeaux, France), C. Taille (Paris, France), D. Kamar (Rueil Malmais, France), C. Thonnelier (Rueil Malmaison, France), A. Lajoinie (Lyon, France), A. Rigault (Lyon, France)

Source: Virtual Congress 2021 – Advances in asthma treatment: monoclonal antibodies
Session: Advances in asthma treatment: monoclonal antibodies
Session type: E-poster
Number: 3731

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Humbert (Le Kremlin-Bicêtre, France), A. Bourdin (Montpellier, France), A. Deschildre (Lille, France), M. Molimard (Bordeaux, France), C. Taille (Paris, France), D. Kamar (Rueil Malmais, France), C. Thonnelier (Rueil Malmaison, France), A. Lajoinie (Lyon, France), A. Rigault (Lyon, France). Omalizumab exposure patterns in real-life: An 11-year French population-based study of 19,203 patients with severe asthma.. 3731

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
12-year follow-up of the epidemiological study for the genetics and environment of asthma (EGEA) – asthma incidence: preliminary results
Source: Eur Respir J 2006; 28: Suppl. 50, 238s
Year: 2006

Increased mortality in patients with corticosteroid-dependent asthma: a nationwide population-based study
Source: Eur Respir J, 54 (5) 1900804; 10.1183/13993003.00804-2019
Year: 2019



Real-life effectiveness of omalizumab in difficult-to-treat versus severe asthma: a national cohort study in Belgium
Source: ERJ Open Res, 5 (4) 00253-2018; 10.1183/23120541.00253-2018
Year: 2019



Real-world exacerbation rates in Japanese patients with COPD: results from the EXACOS observational cohort study
Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations
Year: 2021


Cross-sectional, observational study to estimate the prevalence of the eosinophilic phenotype for Brazilian patients with severe asthma: the BRAEOS study
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020


Effectiveness of omalizumab in Canadian patients with allergic asthma: A retrospective study.
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017

Trends in asthma incidence in children: a UK population-based cohort study
Source: Virtual Congress 2021 – Highlights for primary care in 2021
Year: 2021



Effect of asthma exacerbation during pregnancy in women with asthma: a population-based cohort study
Source: Eur Respir J, 55 (2) 1901335; 10.1183/13993003.01335-2019
Year: 2020



Temporal change in pediatric asthma exacerbation rates - a nationwide Swedish asthma cohort (HERA)
Source: Virtual Congress 2021 – Paediatric asthma and bronchopulmonary dysplasia
Year: 2021


Characteristics of asthma patients with frequent exacerbations – an observational study in Sweden
Source: International Congress 2017 – Primary care management of asthma and self-management of respiratory disease
Year: 2017

Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018




Neomacrolides in the treatment of patients with severe asthma and/or bronchiectasis: A retrospective observational study
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010


The patterns of inadequate drug administration in children with asthma: a multi-center retrospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

Risk of future exacerbations among COPD patients – a real-world register-based cohort study (AvoidEx)
Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities
Year: 2020




The changing pattern of physician-diagnosed respiratory disease in children; a six-year cross-sectional study of Scottish general practice
Source: Eur Respir J 2004; 24: Suppl. 48, 168s
Year: 2004

Rhinitis and onset of asthma: a 20-year prospective study of a random population sample
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017

Non-adherence and sub-optimal treatment with asthma medications in young adults: a population-based cohort study
Source: Virtual Congress 2021 – Asthma burden and management I
Year: 2021


Home dampness, molds and allergic rhinitis in childhood: a six-year population-based cohort study
Source: Annual Congress 2009 - Environmental factors, susceptibility, asthma and COPD
Year: 2009

Prevalence of severe asthma – results from a population-based study.
Source: International Congress 2019 – Asthma and the world
Year: 2019


The APEX study: A retrospective review of outcomes in patients with severe allergic asthma who were or were not hospitalised in the year prior to omalizumab initiation in UK clinical practice
Source: Annual Congress 2012 - Clinical aspects and treatment of asthma and allergic respiratory diseases
Year: 2012